Skip to content

Scailyte and MaxiVAX Solve Clinical Challenges with Data-Driven Collaboration

Scailyte and MaxiVAX proudly announce their collaboration to improve patient outcomes.

Scailyte and MaxiVAX proudly announce their collaboration to improve patient outcomes.

Scailyte and MaxiVAX, two cutting-edge precision medicine organizations, proudly announce their collaboration to improve patient outcomes.

Recognizing the potential of data-driven insights in informing and improving clinical outcomes, MaxiVAX sought a partner with expertise in data analytics. In this collaboration, Scailyte conducted a retrospective multi-omic analysis of phase IIa clinical single arm trial data for MaxiVAX’s lead cancer vaccine candidate, with the goal of characterizing the biological determinants of patient response.

By integrating advanced data analytics into MaxiVAX clinical programs, the collaboration has yielded valuable insights that shed light on the benefit:risk ratio of their clinical candidate, supporting decisions related to the clinical development of this molecule.

“Scailyte has deployed advanced AI and analytics to key clinical data, with the aim of unveiling relevant insights to support MaxiVAX’ decisions on the next development milestones,” said Corinne Solier, SVP Corporate & Technology Development at Scailyte. “With a commitment to scientific rigor and excellence, this partnership exemplified the power of data-driven decision-making”.

“Scailyte has been instrumental in analyzing phase IIa clinical single arm trial data of our most advanced development program” said Thomas Mehrling, MD PhD, CEO of MaxiVAX. “Scailyte’s scientific expertise, communication style and agility are commendable”, added Thomas.

Moving forward, Scailyte and MaxiVAX remain committed to pushing the boundaries of innovation and unlocking the potential of data-driven healthcare for the betterment of patient prognoses. 

About Scailyte

Scailyte is a Swiss-based start-up specialized in generating actionable insights/biosignatures from multi-omics single-cell data using artificial intelligence (AI). Our AI platform, ScaiVision, combines features to integrate different datasets, is indication- and cell-type agnostic and uses data augmentation and a cluster-free approach to extract relevant information while retaining single-cell resolution. These features result in very high discovery success rates from a limited number of samples, with actionable insights for the basis of assay development. 

With a commitment to excellence, Scailyte empowers partners to transform data into actionable intelligence informing  decision making and driving innovation.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

About MaxiVAX

MaxiVAX is a clinical-stage biotechnology company advancing patient-specific immunomodulatory strategies for the treatment of cancers. The company was founded in 2005 and is dedicated to efficiently progressing potential best-in-class anti-cancer immunotherapies to address significant unmet medical needs and improve outcomes for people with difficult-to-treat cancer.

For more information, visit www.maxivax.ch and connect on @LinkedIn.

Recent News

Inside Scailyte – Episode 6: Meet Julian Spagnuolo

In this episode, Julian shares his insights into the intersection of data science and immunology, hi...

Read more

Recent News

Meet Scailyte at Immuno-Oncology 360° in New York, USA

Our very own Diana Stoycheva and Peter Nestorov will be representing Scailyte at the conference at b...

Read more

Recent News

Inside Scailyte – Episode 5: Meet Daniel Schoener

Join us as we introduce you to Daniel Schoener, Executive Business Advisor at Scailyte AG. Daniel's ...

Read more

Recent News

ScaiDigest Volume 7: Unveiling Insights into Autoimmune Diseases

We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...

Read more

Recent News

Inside Scailyte – Episode 4: Meet Peter Evans

In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...

Read more

Recent News

Inside Scailyte – Episode 3: Meet Peter Nestorov

Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...

Read more

Recent News

Festival of Genomics 2024

Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...

Read more

Recent News

Inside Scailyte - Episode 2: Filipa Teixeira

We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...

Read more

Recent News

01 /04

Inside Scailyte – Episode 6: Meet Julian Spagnuolo

In this episode, Julian shares his insights into the intersection of data science and immunology, hi...

Read more

Meet Scailyte at Immuno-Oncology 360° in New York, USA

Our very own Diana Stoycheva and Peter Nestorov will be representing Scailyte at the conference at b...

Read more

Recent News

02 /04

Inside Scailyte – Episode 5: Meet Daniel Schoener

Join us as we introduce you to Daniel Schoener, Executive Business Advisor at Scailyte AG. Daniel's ...

Read more

ScaiDigest Volume 7: Unveiling Insights into Autoimmune Diseases

We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...

Read more

Recent News

03 /04

Inside Scailyte – Episode 4: Meet Peter Evans

In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...

Read more

Inside Scailyte – Episode 3: Meet Peter Nestorov

Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...

Read more

Recent News

04 /04

Festival of Genomics 2024

Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...

Read more

Inside Scailyte - Episode 2: Filipa Teixeira

We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...

Read more

Recent News